𝛼SK or Search

ENTITY

Ascentage Pharma (6855 HK)

69

Analysis

Health Care • China

Ascentage Pharma is a clinical-stage biotechnology company focused on discovering, developing, and commercializing novel small-molecule therapies for cancers, hepatitis B virus, and certain age-related diseases. The company specializes in therapies that inhibit protein-protein interactions to restore programmed cell death, with lead assets including olverembatinib and lisaftoclax for hematological malignancies. Ascentage Pharma was founded in 2009 and is headquartered in Suzhou, China.

more

Refresh

Exchange Announcement • 28 Sep 2026 22:45

Voluntary Announcement - Acquisition Of Shares By The Chairman And Executive Director

Exchange Announcement • 28 Sep 2026 22:34

Voluntary Announcement - Purchase Of Shares By The Trustee For The Purpose Of The 2022 Rsu Scheme

Exchange Announcement • 17 Sep 2026 20:54

Voluntary Announcement - Purchase Of Shares By The Trustee For The Purpose Of The 2022 Rsu Scheme

Exchange Announcement • 17 Sep 2026 07:42

Interim Report 2026

Exchange Announcement • 20 Aug 2026 07:00

Announcement Of Unaudited Interim Results For The Six Months Ended June 30, 2026

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x